Erlotinib HCL and Intermediate
Name:Erlotinib HCL and Intermediate
Synonyms:N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; Tarceva
CAS:183319-69-9
Molecular Formula: C22H23N3O4.HCl
Molecular Weight: 429.90 [g/mol]
Specifications: Enterprise standard,BP,USP.
MSDS: ERLOTINIB HYDROCHLORIDE.PDF
Capacity: Against purchase Order, custom-tailor, Stock
Period of validity: ---- (Kept air tightly in a light-proof, dry and cool place)
Risk /Safety Statements: ---
Free encyclopedia: Erlotinib hydrochloride (Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche
Property:-----
Capacity: 5,
